Key Details
Price
$225.44Last Dividend
$0.57TTM Dividend Yield
0.97%PE Ratio
51.47Annual ROE
6.10%Beta
0.49Events Calendar
Next earnings date:
May 8, 2025Recent quarterly earnings:
Feb 5, 2025Recent annual earnings:
May 8, 2024Next ex-dividend date:
Feb 20, 2025Recent ex-dividend date:
Nov 19, 2024Next split:
N/ARecent split:
Aug 25, 1998Analyst ratings
Recent major analysts updates
Market Data
Price
Market cap
Technical
Dividend
Events
Dividend per share
Dividend yield
Other
Profitability
Revenue
Profit
EPS
ROA & ROE
EBIT & EBITDA
Valuation
PE Ratio
PB Ratio
PS Ratio
Enterprise value
EV/EBITDA
Financial Health
Liquidity
Leverage
Risk & Stability
Balance Sheet
Assets
Equity
Liabilities
Debt
Expenses
Cash Flow
Cashflow Activities
Free CashFlow
CAPEX
Institutional Ownership
STERIS plc (NYSE:STE) will hold its Q3 2025 Earnings Conference Call on February 6, 2025, at 9:00 AM ET. The call will feature company representatives including Julie Winter from Investor Relations, Mike Tokich, the CFO, and Dan Carestio, the CEO. Participants from various financial firms will also join the call, but all attendees will be in listen-only mode.
While the revenue and earnings per share (EPS) for Steris (STE) provide insight into its performance for the quarter ending December 2024, it could be helpful to look at how these important figures stack up against Wall Street predictions and last year's results.
Steris (STE) reported quarterly earnings of $2.32 per share, matching the Zacks Consensus Estimate. This is an increase compared to earnings of $2.22 per share from the same period last year.
On Wednesday, Steris, a company that makes medical equipment, reduced its yearly profit expectations due to the effects of a stronger dollar.
DUBLIN, IRELAND, Feb. 05, 2025 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) has shared its financial results for the third quarter of fiscal 2025, which ended on December 31, 2024. The company's total revenue from ongoing operations rose by 6% to $1.4 billion, up from $1.3 billion in the same quarter of fiscal 2024. Additionally, the constant currency organic revenue from continuing operations also saw a 6% increase.
To better understand how Steris (STE) might perform in the quarter ending December 2024, look beyond Wall Street's basic profit and loss predictions. Instead, focus on the estimates for some of its important metrics. This will give you a clearer picture of its potential performance.
DUBLIN, IRELAND, Jan. 28, 2025 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) has announced that it will pay a quarterly interim dividend of $0.57 per share. This dividend will be paid on March 21, 2025, to shareholders who are on record as of the end of business on February 20, 2025.
Are you looking for ways to choose powerful stocks that can outperform the market for your investment portfolio? The Zacks Style Scores can help you with that.
STE anticipates that its bioprocessing income will increase in the latter part of fiscal 2025.
DUBLIN, IRELAND, Jan. 22, 2025 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) has announced that it will hold a conference call to go over its financial results for the third quarter of fiscal 2025 at 9:00 a.m. ET on February 6, 2025. People can listen to the call live at www.steris-ir.com or by calling 1-833-535-2199 in the U.S. or 1-412-902-6776 internationally and requesting to join the STERIS plc conference call.
FAQ
- What is the ticker symbol for STERIS?
- Does STERIS pay dividends?
- What sector is STERIS in?
- What industry is STERIS in?
- What country is STERIS based in?
- When did STERIS go public?
- Is STERIS in the S&P 500?
- Is STERIS in the NASDAQ 100?
- Is STERIS in the Dow Jones?
- When was STERIS's last earnings report?
- When does STERIS report earnings?
- Should I buy STERIS stock now?